123 related articles for article (PubMed ID: 26874306)
41. Dimeric flavonoids from Arrabidaea brachypoda and assessment of their anti-Trypanosoma cruzi activity.
da Rocha CQ; Queiroz EF; Meira CS; Moreira DR; Soares MB; Marcourt L; Vilegas W; Wolfender JL
J Nat Prod; 2014 Jun; 77(6):1345-50. PubMed ID: 24871307
[TBL] [Abstract][Full Text] [Related]
42. Activity of "reversed" diamidines against Trypanosoma cruzi "in vitro".
Silva CF; Batista MM; Mota RA; de Souza EM; Stephens CE; Som P; Boykin DW; Soeiro Mde N
Biochem Pharmacol; 2007 Jun; 73(12):1939-46. PubMed ID: 17462605
[TBL] [Abstract][Full Text] [Related]
43. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.
Martín-Escolano R; Martín-Escolano J; Ballesteros-Garrido R; Cirauqui N; Abarca B; Rosales MJ; Sánchez-Moreno M; Ballesteros R; Marín C
Parasitol Res; 2020 Sep; 119(9):2943-2954. PubMed ID: 32607710
[TBL] [Abstract][Full Text] [Related]
44. Trypanocidal Activity of Long Chain Diamines and Aminoalcohols.
Legarda-Ceballos AL; del Olmo E; López-Abán J; Escarcena R; Bustos LA; Fonseca-Berzal C; Gómez-Barrio A; Dib JC; San Feliciano A; Muro A
Molecules; 2015 Jun; 20(6):11554-68. PubMed ID: 26111182
[TBL] [Abstract][Full Text] [Related]
45. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS
Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438
[TBL] [Abstract][Full Text] [Related]
46. Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi.
Martín-Escolano R; Moreno-Viguri E; Santivañez-Veliz M; Martin-Montes A; Medina-Carmona E; Paucar R; Marín C; Azqueta A; Cirauqui N; Pey AL; Pérez-Silanes S; Sánchez-Moreno M
J Med Chem; 2018 Jul; 61(13):5643-5663. PubMed ID: 29883536
[TBL] [Abstract][Full Text] [Related]
47. A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives.
Paucar R; Martín-Escolano R; Moreno-Viguri E; Cirauqui N; Rodrigues CR; Marín C; Sánchez-Moreno M; Pérez-Silanes S; Ravera M; Gabano E
Eur J Med Chem; 2019 Feb; 163():569-582. PubMed ID: 30554132
[TBL] [Abstract][Full Text] [Related]
48. Identification of Pyrazolo[3,4-e][1,4]thiazepin based CYP51 inhibitors as potential Chagas disease therapeutic alternative: In vitro and in vivo evaluation, binding mode prediction and SAR exploration.
Ferreira de Almeida Fiuza L; Peres RB; Simões-Silva MR; da Silva PB; Batista DDGJ; da Silva CF; Nefertiti Silva da Gama A; Krishna Reddy TR; Soeiro MNC
Eur J Med Chem; 2018 Apr; 149():257-268. PubMed ID: 29501946
[TBL] [Abstract][Full Text] [Related]
49. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
50. Primary targets of the sesquiterpene lactone deoxymikanolide on Trypanosoma cruzi.
Puente V; Laurella LC; Spina RM; Lozano E; Martino VS; Sosa MA; Sülsen VP; Lombardo E
Phytomedicine; 2019 Mar; 56():27-34. PubMed ID: 30668348
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
[TBL] [Abstract][Full Text] [Related]
52. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
[TBL] [Abstract][Full Text] [Related]
53. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice.
Barr SC; Rose D; Jaynes JM
J Parasitol; 1995 Dec; 81(6):974-8. PubMed ID: 8544074
[TBL] [Abstract][Full Text] [Related]
54. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
da Paixão VG; Pita SSDR
Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
[TBL] [Abstract][Full Text] [Related]
55. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.
Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA
J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents.
Suto Y; Nakajima-Shimada J; Yamagiwa N; Onizuka Y; Iwasaki G
Bioorg Med Chem Lett; 2015 Aug; 25(15):2967-71. PubMed ID: 26037321
[TBL] [Abstract][Full Text] [Related]
57. In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi.
Silva CF; Batista Dda G; Batista MM; Lionel J; Hammer ER; Brun R; Soeiro Mde N
Parasitology; 2014 Mar; 141(3):367-73. PubMed ID: 24553079
[TBL] [Abstract][Full Text] [Related]
58. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease.
Martín-Escolano R; Cebrián R; Maqueda M; Romero D; Rosales MJ; Sánchez-Moreno M; Marín C
J Antimicrob Chemother; 2020 Jun; 75(6):1537-1545. PubMed ID: 32129856
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
[TBL] [Abstract][Full Text] [Related]
60. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
Arantes JM; Francisco AF; de Abreu Vieira PM; Silva M; Araújo MS; de Carvalho AT; Pedrosa ML; Carneiro CM; Tafuri WL; Martins-Filho OA; Elói-Santos SM
Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
